摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(1-Ethyl-1,6-dihydro-6-oxo-3-pyridazinyl)-4-piperidinyl 4-(1-methylethyl)-1-piperazinecarboxylate | 1542135-77-2

中文名称
——
中文别名
——
英文名称
1-(1-Ethyl-1,6-dihydro-6-oxo-3-pyridazinyl)-4-piperidinyl 4-(1-methylethyl)-1-piperazinecarboxylate
英文别名
[1-(1-ethyl-6-oxopyridazin-3-yl)piperidin-4-yl] 4-propan-2-ylpiperazine-1-carboxylate
1-(1-Ethyl-1,6-dihydro-6-oxo-3-pyridazinyl)-4-piperidinyl 4-(1-methylethyl)-1-piperazinecarboxylate化学式
CAS
1542135-77-2
化学式
C19H31N5O3
mdl
——
分子量
377.5
InChiKey
NQFIPWSBOZOBAK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.9
  • 重原子数:
    27
  • 可旋转键数:
    5
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.74
  • 拓扑面积:
    68.7
  • 氢给体数:
    0
  • 氢受体数:
    5

文献信息

  • [EN] CARBAMATE/UREA DERIVATIVES<br/>[FR] DÉRIVÉS DE CARBAMATE/URÉE
    申请人:NOVARTIS AG
    公开号:WO2014013469A1
    公开(公告)日:2014-01-23
    The invention relates to compound of the formula (I) or a salt thereof, wherein the substituents are as defined in the specification; to its preparation, to its use as medicament and to medicaments comprising it.
    这项发明涉及公式(I)的化合物或其盐,其中取代基如规范中所定义;涉及其制备,涉及其作为药物的用途,以及包含它的药物。
  • Carbamate/urea derivatives
    申请人:AUBERSON Yves
    公开号:US20140163036A1
    公开(公告)日:2014-06-12
    The invention relates to compound of the formula I or a salt thereof, wherein the substituents are as defined in the specification; to its preparation, to its use as medicament and to medicaments comprising it.
    该发明涉及公式I的化合物或其盐,其中取代基如规范中所定义;涉及其制备,用作药物以及包含它的药物。
  • [EN] NEW PROCESS FOR THE PREPARATION OF 2-CYCLOPENTYL-6-METHOXY-ISONICOTINIC ACID<br/>[FR] NOUVEAU PROCÉDÉ DE PRÉPARATION D'ACIDE 2-CYCLOPENTYL-6-MÉTHOXY-ISONICOTINIQUE
    申请人:ACTELION PHARMACEUTICALS LTD
    公开号:WO2013175397A1
    公开(公告)日:2013-11-28
    The present invention relates to new processes for the preparation of 2-cyclopentyl-6-methoxy-isonicotinic acid, which is a useful intermediate for the synthesis of pyridine-4-yl derivatives as immunomodulating agent. Moreover, the present invention also relates to new intermediates used in those processes.
    本发明涉及一种制备2-环戊基-6-甲氧基吡啶-4-基甲酸的新工艺,该化合物是合成吡啶-4-基衍生物作为免疫调节剂的有用中间体。此外,本发明还涉及用于这些工艺的新中间体。
  • NEW PROCESS FOR THE PREPARATION OF 2-CYCLOPENTYL-6-METHOXY-ISONICOTINIC ACID
    申请人:ACTELION PHARMACEUTICALS LTD
    公开号:US20150133669A1
    公开(公告)日:2015-05-14
    The present invention relates to new processes for the preparation of 2-cyclopentyl-6-methoxy-isonicotinic acid, which is a useful intermediate for the synthesis of pyridine-4-yl derivatives as immunomodulating agent. Moreover, the present invention also relates to new intermediates used in those processes.
    本发明涉及制备2-环戊基-6-甲氧基异烟酸的新工艺,该化合物是合成吡啶-4-基衍生物免疫调节剂的有用中间体。此外,本发明还涉及在这些工艺中使用的新中间体。
  • CARBAMATE/UREA DERIVATIVES
    申请人:AUBERSON Yves
    公开号:US20150218127A1
    公开(公告)日:2015-08-06
    The invention relates to compound of the formula I or a salt thereof, wherein the substituents are as defined in the specification; to its preparation, to its use as medicament and to medicaments comprising it.
    本发明涉及式I的化合物或其盐,其中取代基如规范中所定义;其制备方法;其作为药物的用途及包含它的药物。
查看更多